If a family member, friend, or caregiver needs to give vemurafenib to you, they also need to follow these steps. Tell your healthcare provider right away if you experience yellowing of. Vemurafenib is a cyp3a4 substrate and cyp1a2 inhibitor avoid coadministration of vemurafenib with strong cyp3a4 inhibitors eg, ketoconazole, itraconazole, clarithromycin, saquinavir, ritonavir, indinavir, nelfinavir, voriconazole and replace and use alternative drugs when possible. Vemurafenib is metabolized by cyp3a4 and the metabolites make up 5% of the components in plasma. Here you will find information and tools you need to stay informed and connected, including. Monitor hepatic function prior to and during treatment see warnings and precautions 5. Action inhibits mutated forms of the enzyme kinase. Zelboraf vemurafenib is supplied as 240 mg filmcoated tablets with vem debossed on one side.
Vemurafenib side effects, dosage, interactions drugs. Dose increase or reduction is recommended based on individual safety and tolerability. Summary of investigation results hydroxyzine hydrochloride, hydroxyzine pamoate. Highlights of prescribing information advanced renal. Vemurafenib is used to treat melanoma skin cancer that. A specific test, approved by fda, known as the braf v600e or braf v600k mutation, is recommended before starting cobimetinib therapy to determine the chance that the medication will kill melanoma cells.
Vemurafenib is a highly efficient braf inhibitor for metastatic melanoma patients carrying the v600 mutation. Zelboraf is a kinase inhibitor indicated for the treatment of patients with unresectable or metastatic melanoma with braf v600e mutation as detected by an fdaapproved test. Vemurafenib does not have antitumour effects against melanoma cell lines with the wildtype braf mutation. Vemurafenib is a competitive smallmolecule serinethreonine kinase inhibitor that functions by binding to the atpbinding domain of mutant braf. Cotellic is a kinase inhibitor indicated for the treatment of patients with unresectable or metastatic melanoma with a braf v600e or v600k mutation, in combination with vemurafenib.
Vemurafenib selectively binds to the atpbinding site of brafv600e kinase and inhibits its activity, which may result in an inhibition of an overactivated mapk signaling pathway downstream in brafv600e kinaseexpressing tumor cells and a reduction. Exposure to ultraviolet radiation and sun sensitivity are additional risk factors for the disease. Zelboraf is not indicated for use in patients with wildtype braf melanoma. Official site for healthcare professionals nexavar. The related drug information index provides comprehensive access to all drug information related to a specific drug types of content include full prescribing information, drug summaries, full prescribing information continuing medication education full pi cme, medication guides, risk evaluation and mitigation strategies rems summaries, rems continuing medication education rems cme, and. If your healthcare provider prescribes zelboraf vemurafenib, also read the medication guide that comes with zelboraf. Vemurafenib blocks these downstream processes to inhibit tumour growth and eventually trigger apoptosis. Vemurafenib definition of vemurafenib by medical dictionary. Zelboraf vemurafenib is a type of cancer treatment called a cancer growth blocker.
Over the course of treatment, patients who tolerate inlyta for at least two consecutive weeks with no adverse reactions grade 2 according to the common toxicity criteria for adverse events ctcae, are normotensive, and are not receiving antihypertension medication, may. Vemurafenib is an orally bioavailable, atpcompetitive, smallmolecule inhibitor of brafv600e kinase with potential antineoplastic activity. Zelboraf vemurafenib is a braf inhibitor that blocks the function of the v600emutated braf protein which can stop the melanoma cells from growing and dividing. The following packaging configurations are available. The recommended tukysa dose reductions and dosage modifications for adverse reactions are provided in. Vemurafenib is active against several human tumor serinethreonine protein kinase braf melanoma xenograft models. Zelboraf vemurafenib is a kinase inhibitor available as 240 mg tablets for oral use. Get emergency medical help if you have signs of an allergic reaction hives, difficult breathing, swelling in your face or throat or a severe skin reaction fever, sore throat, burning in your eyes, skin pain, red or purple skin rash that spreads and causes blistering and peeling seek medical treatment if you have a serious drug reaction that can affect many parts.
See 17 for patient counseling information and medication. It has the molecular formula c 23 h 18 clf 2 n 3 o 3 s and a molecular weight of 489. Nilotinib drug substance, in the form of monohydrochloride monohydrate, is a white to slightly yellowish to slightly greenish yellow powder with the molecular formula and weight, respectively, of c 28 h 22 f 3 n 7 ohcl h 2 o and 584 corresponding molecular formula and weight of nilotinib base, anhydrous are c 28 h 22 f 3 n 7 o and 529. As for all medicines, data on the use of zelboraf are continuously monitored. Zelboraf vemurafenib tablets are indicated for the treatment of patients with unresectable or metastatic melanoma with braf v600e mutation as detected by an fdaapproved test. Get emergency help right away if you get symptoms such as chest pain, shortness of breath, racing heartbeat, swelling in lower legs, feet and abdomen, feel lightheaded or faint, tiredness, nausea, vomiting, or sweat a lot. Cotellic is not indicated for treatment of patients with wildtype braf melanoma.
Vemurafenib tab zelboraf by genentech is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Stivarga regorafenib can cause liver problems, which can be serious and sometimes lead to death. Cotellic is a prescription medicine that is used with the medicine. Sections or subsections omitted from the full prescribing information are not listed. Examples of affected drugs include caffeine, warfarin, among others. Highlights of prescribing information these highlights do. Vemurafenib is also being studied in the treatment of other types of cancer. Gently transfer the vemurafenib from its package to a small medicine or other.
The recommended dose of yervoy ipilimumab is 3 mgkg administered intravenously iv over 90 minutes every 3 weeks for a maximum of 4 doses. Vumerity diroximel fumarate delayedrelease capsules, for oral use. The solubility of sunitinib malate in aqueous media over the range ph 1. In the event of toxicity, doses may be delayed, but all treatment must be administered within 16 weeks of the first dose see clinical studies 14. Determine if patients are taking drugs that could slow heart rate or atrioventricular conduction see warnings and. Hepatotoxicity severe and sometimes fatal hepatotoxicity has occurred in clinical trials see warnings and precautions 5. Vemurafenib is a kinase inhibitor available as 240 mg tablets for.
Easy to read fda package insert, drug facts, dosage and administration, and adverse effects for decadron dexamethasone. Your healthcare provider will do blood tests to check your liver function before you start taking stivarga and during your treatment with stivarga to check for liver problems. Interrupt and then reduce or discontinue stivarga for hepatotoxicity as manifested by elevated liver. Information below provided by the pharmaceutical company. Ervebo ebola zaire vaccine, live suspension for intramuscular injection.
It is used to treat metastatic melanoma skin cancer. The log of the distribution coefficient octanolwater at ph 7 is 5. Zelboraf vemurafenib dosing, indications, interactions. Zelboraf is not indicated for treatment of patients with wildtype braf melanoma. Zelboraf tablets price in india, vemurafenib by genentech. Vemurafenib can slow down the removal of other medications from your body, which may affect how they work. Melanoma that cannot be removed by surgery or has metastasized spread to other parts of the body. Melanoma is a lifethreatening form of skin cancer that occurs due to genetic and environmental factors.
Refer to the dabrafenib prescribing information for recommended dabrafenib dosing information. Vemurafenib is approved to treat patients whose disease has a certain mutation in the braf gene, including. Pharmaceuticals and medical devices agency of japan. D indications genetic implication treatment of unresectable or metastatic melanoma with braf v600emutation. Zelboraf fda prescribing information, side effects and uses. Vemurafenib is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Vemurafenib has favorable pharmacokinetics as compared to the other structurally similar braf v600 mutated kinases. It is used to treat melanoma, a type of skin cancer, and. Package inserts revised for vemurafenib, hydroxyzine in. Sunitinib malate is a yellow to orange powder with a pka of 8. Highlights of prescribing information tafinlar with.
Highlights of prescribing information these highlights. The newly approved drug zelboraf appears to nearly double the length of time a person can expect to live with advanced melanoma skin cancer, a new study shows. Side effects reported with zelboraf are carefully evaluated and any necessary action taken to protect patients. Braftovi encorafenib capsules, for oral use initial u. Vemurafenib has the chemical name propane1sulfonic acid 354chlorophenyl1hpyrrolo2,3bpyridine3carbonyl 2,4difluorophenylamide. It inhibits braf v600e and also has inhibitory activity in vitro against several other kinds of kinases, including craf, araf and wildtype braf. Dermatologic toxicities occurred in 90% of patients and were severe ncictc grade 3 and higher in 15% of patients receiving vectibix monotherapy see dosage and administration 2. This product information was approved at the time this auspar was published. Zelboraf may double survival for some melanoma patients. Gloves are not necessary if you give the drug to yourself. Skyrizi risankizumabrzaa full prescribing information. Highlights of prescribing information perforation can.
Everyone living with a cancer diagnosis could use some support along the way. The risk factors most associated with malignant melanoma include a family history of melanoma, atypical moles, and previous melanoma. It belongs to a group of cancer fighting medications called antineoplastics, and more specifically to a group of medications called monoclonal antibodies. Zelboraf vemurafenib cost, side effects, dosage for. Vemurafenib is a medicine that targets proteins in cancer cells and stops the cancer cells from growing. See full prescribing information for complete boxed. Product information for auspar zelboraf vemurafenib roche products pty ltd pm20110079534 final 17 december 2012. Ndc 5024209001 single bottle of 120 count ndc 5024209002 single bottle of 112 count.
654 1174 3 1018 916 1259 700 1167 1501 656 869 1481 534 790 1029 700 1184 430 1077 254 920 35 856 448 925 561 1280 1355 918 1473 157 518 435 719 80 456 1038 1137 939 1432 1175 158 759 457 86